Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

With the right excipients, formulators can control when, where, and how an API is released.

Selecting Excipients for Controlled Release

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

New approaches enable more patient-centric drug design that offers improved outcomes.

Emerging Technologies Advance Oral Drug Delivery

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Assessing potential formulation and manufacturing issues in early development phases can improve a drug’s chances for success.

Can Early Development Strategies Avoid Later-Stage Disasters?

Orbis Biosciences’ Optimµm Platform delivers microparticulate dosage forms with controlled-release and taste-masked properties in a single manufacturing step. 

Manufacturing Microparticles in a Single Step

Modified-release lipid-based formulations in softgel capsules can address physiochemical and pharmacokinetic challenges posed by drug compounds. 

Bringing Together the Benefits of Lipid-Based Formulations and Modified-Release Drug Delivery

Tom Tice, PhD, is senior director, Global Technical Marketing, Evonik Industries.

Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.

A 30-Year History of PLG Applications in Parenteral Controlled Drug Release

The patent was filed for a chewing gum composition with controlled release of cannabinoids and opioid agonists, and antagonists for addiction or dependence treatment. 


AXIM Files Patent Application for Controlled-Release Chewing Gum for Opioid Addiction

Edward Godek is manager of process and technical operations at Glatt Air Techniques, NJ, info.gat@glatt.com.

Chris O’Callaghan is senior product manager at Innopharma Technology, Dublin, Ireland, ocallaghanc@innopharmalabs.com.

Ian Jones, PhD, is founder and CEO of Innopharma Technology and Innopharma College of Applied Sciences, Dublin

Piyush Patel, is formulation technologies manager at Colorcon, PA, ppatel@colorcon.com.

Process analytical technology, based on monitoring particle size distribution and tracking coating thickness measurements in real time, can be used to predict the dissolution of polymer-coated multiparticulates.

Predicting Multiparticulate Dissolution in Real Time for Modified- and Extended- Release Formulations

A capsule technology for enteric protection and delayed release without a functional coating

Emerging controlled-release technologies could lead to more effective therapies in the near future.

Formulation and Drug Delivery, Controlled Release